This document provides information about semisolid dosage forms including ointments, creams, and gels. It discusses the definition, advantages, disadvantages, ideal properties, ingredients used in preparation, methods of preparation, and evaluation of these topical dosage forms. The key components discussed include bases, preservatives, emulsifiers, gelling agents, and antioxidants. Methods of preparation depend on the formulation and can include incorporation, fusion, or emulsification. Evaluation tests assess properties like penetration, release of active ingredients, irritation effects, and stability.
Suspension, interfacial properties of suspended particles, settling in suspensions, formulation of flocculated and deflocculated suspensions. Emulsions and theories of emulsification, microemulsion and multiple emulsions; Stability of emulsions, preservation of emulsions, rheological properties of emulsions.
An excipient is generally a pharmacologically inactive substance used as a carrier for the active ingredients of a medication
EXCIPIENTS USED IN LIQUID DOSAGE FORMS:
Solvents/co-solvents ,
Buffering agents,
Preservatives,
Anti-oxidants,
Humectants,
Wetting agents,
Anti-foaming agents,
Thickening agents,
Sweetening agents,
Flavouring agents,
EXCIPIENTS USED IN TABLETS:
Binders
Coatings
Disintegrants
Fillers
Flavours
Colours
Lubricants
Glidants
Preservatives
Sweeteners
Semisolid dosage forms: Definitions, classification, mechanisms and factors influencing dermal penetration of drugs. Preparation of ointments, pastes, creams and gels. Excipients used in semi solid dosage forms. Evaluation of semi solid dosages forms
Pharmaceutical excipients are pharmacologically inert substances which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form to alter the functions.
a suspension is a heterogeneous mixture containing solid particles that are sufficiently large for sedimentation. Usually they must be larger than one micrometer. A suspension is a heterogeneous mixture in which the solute particles do not dissolve but get suspended throughout the bulk of the medium.
Liquid dosage forms are effective pharmaceutical products containing a mixture of active pharmaceutical ingredients (API/Drug) and non drug components (excipients). It is a dose of a drug used as a medicine for consumption or administration. Many liquid dosage forms are used in the pharmacy, but the most commonly used are syrup, suspension, and elixirs. The general category of liquid oral doses includes a broad range of dosage forms, broadly classified as monophasic and biphasic. Whereas dosage forms in both types comprise at least one drug, monophasic forms are homogeneous and completely dissolve in liquid, whereas biphasic forms in a vehicle do not dissolve.
Preformulation Studies: Introduction to preformulation, goals and objectives, study of
physicochemical characteristics of drug substances.
a. Physical properties: Physical form (crystal & amorphous), particle size, shape, flow
properties, solubility profile (pKa, pH, partition coefficient), polymorphism.
b. Chemical Properties: Hydrolysis, oxidation, reduction, racemisation, polymerization
BCS classification of drugs & its significant
Application of preformulation considerations in the development of solid, liquid oral and
parenteral dosage forms and its impact on stability of dosage forms.
A detailed study on tablets, its classification, excipients, tablet granulation, methods of granulation, compression machines, equipment tooling and the problems that occur during the tablet manufacturing process. This presentation is based on the PCI syllabus for bpharm students of fifth semester.
Suspension, interfacial properties of suspended particles, settling in suspensions, formulation of flocculated and deflocculated suspensions. Emulsions and theories of emulsification, microemulsion and multiple emulsions; Stability of emulsions, preservation of emulsions, rheological properties of emulsions.
An excipient is generally a pharmacologically inactive substance used as a carrier for the active ingredients of a medication
EXCIPIENTS USED IN LIQUID DOSAGE FORMS:
Solvents/co-solvents ,
Buffering agents,
Preservatives,
Anti-oxidants,
Humectants,
Wetting agents,
Anti-foaming agents,
Thickening agents,
Sweetening agents,
Flavouring agents,
EXCIPIENTS USED IN TABLETS:
Binders
Coatings
Disintegrants
Fillers
Flavours
Colours
Lubricants
Glidants
Preservatives
Sweeteners
Semisolid dosage forms: Definitions, classification, mechanisms and factors influencing dermal penetration of drugs. Preparation of ointments, pastes, creams and gels. Excipients used in semi solid dosage forms. Evaluation of semi solid dosages forms
Pharmaceutical excipients are pharmacologically inert substances which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form to alter the functions.
a suspension is a heterogeneous mixture containing solid particles that are sufficiently large for sedimentation. Usually they must be larger than one micrometer. A suspension is a heterogeneous mixture in which the solute particles do not dissolve but get suspended throughout the bulk of the medium.
Liquid dosage forms are effective pharmaceutical products containing a mixture of active pharmaceutical ingredients (API/Drug) and non drug components (excipients). It is a dose of a drug used as a medicine for consumption or administration. Many liquid dosage forms are used in the pharmacy, but the most commonly used are syrup, suspension, and elixirs. The general category of liquid oral doses includes a broad range of dosage forms, broadly classified as monophasic and biphasic. Whereas dosage forms in both types comprise at least one drug, monophasic forms are homogeneous and completely dissolve in liquid, whereas biphasic forms in a vehicle do not dissolve.
Preformulation Studies: Introduction to preformulation, goals and objectives, study of
physicochemical characteristics of drug substances.
a. Physical properties: Physical form (crystal & amorphous), particle size, shape, flow
properties, solubility profile (pKa, pH, partition coefficient), polymorphism.
b. Chemical Properties: Hydrolysis, oxidation, reduction, racemisation, polymerization
BCS classification of drugs & its significant
Application of preformulation considerations in the development of solid, liquid oral and
parenteral dosage forms and its impact on stability of dosage forms.
A detailed study on tablets, its classification, excipients, tablet granulation, methods of granulation, compression machines, equipment tooling and the problems that occur during the tablet manufacturing process. This presentation is based on the PCI syllabus for bpharm students of fifth semester.
Semisolid Dosage Form: Ointment, creams & Gel.
Learn more with me Asst. Prof. Mr. Manohar D. Kengar, Nootan College of Pharmacy, Kavathemahankal.
Suppository Dosage Form: Type of Suppository, Preparation method, Evaluation
https://youtu.be/NUgFoLuT3cs
his presentation delves into the formulation, advantages, and applications of semisolid dosage forms, including creams, ointments, and gels. Learn about their unique properties, manufacturing processes, and considerations for drug delivery. Whether you're a student or a pharmaceutical professional, this presentation offers valuable insights into this essential aspect of medication delivery.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
2. Semisolid dosage form
• INTRODUCTION
• Pharmaceutical semisolid dosage preparations
include :ointments, pastes, cream, plasters, gels
and rigid foams.
• They contain one or more active ingredients
dissolved or uniformly dispersed in a suitable base
and any suitable excipients such as emulsifiers,
viscosity increasing agents, anti microbial agents,
antioxidants, or stabilizing agents etc..
3. DEFINITION
• Semi solids are the topical dosage form used
for the therapeutic, protective or cosmetic
function. They may be applied to the skin, or
used nasally, vaginally, or rectally…
4. Advantage of semi-solid dosage form:
• It is used externally
• Probability of side effect can be reduce
• First pass gut and hepatic metabolism is avoided.
• Local action and Site specific action of drug on
affected area.
• Convenient for unconscious patient or patient
having difficulty on oral administration.
• Suitable dosage form for bitter drugs.
• More stable than liquid dosage form
5. Disadvantages of semi-solid dosage
form:
• There is no dosage accuracy in this type of dosage
form
• The base which is used in the semi-solid dosage form
can be easily oxidized.
• May cause staining.
•
•
•
•
They are bulky to handle.
Application with finger may cause contamination.
Physico-chemically less stable than solid dosage
form.
May cause irritation or allergy to some patients
6. IDEAL PROPERTIES OF
SEMISOLIDS
• PHYSICAL PROPERTIES:
• Smooth texture
• Elegant in appearance
• Non dehydrating
• Non gritty
• Non greasy and non staining
• Non hygroscopic
7. IDEAL PROPERTIES OF
SEMISOLIDS
• PHYSIOLOGICAL PROPERTIES
• Non irritating
• Do not alter membrane / skin functioning
•
•
Miscible with skin secretion
Have low sensitization index
• APPLICATION PROPERTIES
•
•
Easily applicable with efficient drug release.
High aqueous wash ability.
8. PREPARATION OF SEMISOLIDS
DOSAGE FORMS
INGREDIENTS USED IN PREPARATION:
• Bases
• Preservative
• Humectants
• Antioxidants
• Emulsifier
• Gelling agent
• Permeation enhancer
• Buffers
9. 1. BASES:
• It is one of the most important ingredient used
in formulation of semisolid dosage form.
Ointment bases do not merely act as the
carriers of the medicaments, but they also
control the extent of absorption of
medicaments incorporated in them.
10. 1. BASES:
IDEAL PROPERTIES OF A BASE:
They should be:
• Inert, non-irritating and non-sensitizing.
• Compatible with skin pH and the drug.
• Good solvent and/or emulsifying agent.
• Emollient, protective, non-greasy and easily
removable.
• Release medicament readily at the site of application.
• Pharmaceutically elegant and possess good stability
11. CLASSIFICATION OF
BASES :
Ointments bases are classified by the
USP into four general groups:
A- hydrocarbon bases (oleaginous bases)
(Petrolatum , Paraffin, Lanolin…..)
B- absorption bases (cold cream, anhydrus
lanolin …)
C- water-removable bases ( oil in water)
D- water-soluble bases (polyethylene glycol)
12. ANTIOXIDANTS :
Oxygen is a highly reactive atom that is capable
of becoming part of potentially damaging
molecules commonly called “free radicals.”
Free radicals are capable of attacking the
healthy cells of the body, causing them to lose
their structure and function. To prevent this
an antioxidants are added.
E.g. Butylated hydroxy anisole, Butylated
hydroxy toluene
13. PERMEATION ENHANCERS :
• Skin can act as a barrier. With the introduction
of various penetration enhancers, penetration
of the drug through the skin can be improved.
• Oleic acid
14. EMULSIFIER :
• An emulsifier (emulgent) is a substance that
stabilizes an emulsion by increasing its kinetic
stability.
- Must reduce surface tension for proper
emulsification.
- Prevents coalescence.
- Ability to increase the viscosity at low
concentration.
15. •Emulsifying agents
- Sodium lauryl sulfate :O/W emulsion
- Sodium stearate and calcium stearate.
- Glyceryl monostearate: weak W/O emulsifying
agents and used as stabilization agents and emollient
in the O/W emulsion.
16. HUMECTANT:
A humectant is a hygroscopic substance, Humectants are used
to :
•
•
•
increase the solubility of the active ingredient
to elevate its skin penetration.
elevate the hydration of the skin.
BUFFERS:
Buffers are added for various purpose such as :
- Compatibility with skin.
- Drug solubility.
- Drug stability.
- Influence ionization of drug. Skin, due to its weak acidic
nature, tolerates weak acidic preparations.
17. •Antimicrobial preservatives
-To inhibit the growth of contaminating microorganisms,
So require the addition of chemical antimicrobial preservatives to
the formulation
-E.G. para-hydroxybenzoates (parabens), phenols,
benzoic acid, sorbic acid, quaternary ammonium
salts and other compounds.
18. 1- Ointments
• Ointments are homogenous, translucent,
viscous semi-solid preparations, most
commonly a greasy, thick oil (oil 80% - water
20%) intended for external application to the
skin or mucous membrane. They are used as:
- Emollients
- Protective
- Therapeutic
- Prophylactic purpose
19. Classification of ointments
A- Epidermic ointments
• These ointments are intended to produce their action
on the surface of the skin and produce local
effect,they are not absorbed.
• They acts as protectives, antiseptics and parasiticides.
B- Endodermic ointments
• These ointments are intended to release the
medicaments that penetrate into the skin. They are
partially absorbed and acts as emollients, stimulants
and local irritants.
C- Diadermic ointments
• These ointments are intended to release the
medicaments that pass through the skin and produce
systemic effects.
21. Preparation of Ointments
- Both on a large and a small scale, ointments are
prepared by three general methods:
(1) incorporation method
(2) fusion method
(3) emulsification method
The method for a particular preparation depends
primarily upon the nature of the ingredients
22. (1) incorporation
-The components of the ointment are mixed together by
various means until a uniform preparation has been
attained.
- On a small scale, the pharmacist may mix the components
of an ointment in a mortar with a pestle, or a spatula
and an ointment slab may be used to rub the ingredients
together.
24. (2) fusion
By the fusion method, all or some of the components of an
ointment are combined by being melted together and cooled
with constant stirring until congealed.
Those components not melted are generally added to the
congealing mixture as it is being cooled and stirred.
Naturally, heat-labile substances and any volatile components
are added last when the temperature of the mixture is low
enough not to cause decomposition of volatilization of the
components.
26. • In the preparation of ointments having an emulsion type of
formula, the general method of manufacture involves a
melting process as well as an emulsification process.
(3) emulsification
27.
28. Evaluation of ointments
A- Penetration
• Weighed quantities of the ointments are
rubbed over definite areas of the skin for a
given length of time. Thereafter the
unabsorbed ointment is collected from the skin
and weighed. The difference between the
two weights roughly represents the amount
absorbed.
29. Evaluation of ointments
B- RATE OF RELEASE OF MEDICAMENT:
• To assess rate of release of medicament, small
amount of the ointment can be placed on the surface
of nutrient agar contained in a Petri dish.
• If the medicament is bactericidal the agar plate is
previously seeded with a suitable organism like
s.aureus. After asuitable period of incubation, the
zone of inhibition is measured and correlated with the
rate of release.
30. RATE OF RELEASE OF
MEDICAMENT
• smear internal surface of test tubes with thin
layers of ointment, fill the tubes with
saline/serum and after a gap of time estimating
the amount of drug present in the serum/saline.
31. Evaluation of ointments
C- ABSORPTION OF MEDICAMENT
INTO
BLOOD STREAM:
• Definite amount of ointments should be
rubbed through the skin. Under standard
conditions and medicaments are estimated in
the blood plasma or urine
32. Evaluation of ointments
D- IRRITANT EFFECT:
• The irritant effect can also be judged to a
certain extent by injecting the ointment into
thigh muscles and under the abdominal skin of
rats. Reaction are noted at intervals of
24,48,72 and 96 hours. Presence of patches on
the skin within 2 weeks indicate irritancy to
pressing skin
33. 2- creams:
Creams are homogeneous, semi-solid preparations
consisting of opaque emulsion ,contains lipophilic
emulsifying agent . Their consistency depend on the
type of emulsion, either water-in-oil (w/o) or oil-in –
water (o/w), and on the nature of the solids in the
internal phase. Creams are intended for the
application to the skin or certain mucous membranes
for:
- Protective
- Therapeutic
- prophylactic purposes
34. Classification of creams
• Creams containing microspheres
( VIT. A CREAM … 200-250 micron)
• Lamellar faced creams
( liquid paraffin in water emulsion )
• Cream containing liquid nanoparticles
(a w/o cream , more occlusive )
35. Preparation of creams
Steps
- Preparation of oil phase :flack/powder
ingredient are dispersed in mineral oil or
silicone oil ) heating may required for melting
- Hydration of aqueous phase: emulsifiers,
stabilizer, thickener are dispersed in water
heating may required for hydrating
- Forming the emulsion: two phases are
blended under vigorous agitation
- Dispersion of active ingredient
36. Evaluation of creams
A- Rheology:
• . The rheology or viscosity should remain
constant. Rheologic measurements are utilized
to characterize the ease of pouring from a
bottle, squeezing from a tube or container
- maintaining product shape in ajar or after
extrusion, rubbing the product onto the skin
• The viscosity can be measured using
viscometers used for such liquids.
37. Evaluation of creams
B- Sensitivity:
As various types of ingredients are used with occasional
use of antiseptic, hormones. etc., there is a possibility
of sensitization or photosensitization of the skin. This
should be tested before hand. This test is normally
done by patch test on skin and can be either open or
occlusive. The test sample is applied along with a
standard market product at different places and effect
is compared after a period of time.
38. Evaluation of creams
C- Effect of thermal stresses:
It is usual to evaluate the stability of an
emulsion by subjecting it too high and low
temperatures in alternating cycles. The
samples are first exposed to 60⁰ C for a few
hours and then to o to 40⁰C. Such exposures
are repeated a number of times and emulsion
stability assessed after each cycle.
39. Evaluation of creams
D- phase separation:
The rate and degree of phase separation in an emulsion
can be easily determined by keeping a certain amount
in a graduated cylinder and measuring the volume of
separated phase after definite time intervals. The
phase separation may result from creaming or
coalescence of globules. The phase separation test
can be accelerated by centrifugation at low/moderate
speeds.
40. 3- Gels:
• Gels are homogeneous, clear, semisolid
systems consisting of dispersions of small or
large molecules in an aqueous liquid vehicle
rendered jellylike by the addition of a gelling
agent.
Gels are aqueous colloidal suspensions of the
hydrated forms of insoluble medicament, used
for medication and lubrication.
41. gelling agents
• Among the gelling agents used
- Synthetic macromolecules, such as carbomer
934
- Cellulose derivatives, such as
carboxymethylcellulose or hydroxypropyl
methylcellulose
- Natural gums, such as tragacanth
42. TYPES OF GEL-
PHASE
Single Phase
Gels in which the
macromolecules are uniformly
distributed throughout a liquid
with no apparent boundaries
between the dispersed
macromolecules and the liquid
Usually involve organics
Two Phase(Domain)
When the gel mass consists of
floccules of small distinct
particles
Usually involve inorganics
44. Evaluation of gels
- Drug content -1gm of gel was accurately weighed in a 50ml
of volumetric flask to which 20ml purified water was added
with continuous shaking. Volume was adjusted with a mixture
of 10% methanol in water. Absorbance of the solution with the
blank was measured at 360nm using UV-spectrophotometer.
- Measurement of pH -The pH of gels were determined by
digital pH meter. One gram of gel was dissolved in 100ml of
distilled water and stored at 4°C for two hours.
45. Evaluation of gels
- Viscosity -Brookfield viscometer is used for
determination of viscosity. Gels were filled in jar
and spindle was lowered perpendicularly taking
care that spindle do not touch bottom of the jar.
The spindle was rotated in the gel at increasing
shear rates 0.5, 1, 2.5 and 5rpm. At each speed,
the corresponding dial reading was noted.
46.
47. Evaluation of gels
- Spreadability- A modified apparatus consisting of
two glass slides containing gel in between with the lower
slide fixed to a wooden plate and the upper one attached
to a balance by a hook was used to determine
spreadability.
- Extrudability - A simple method was adopted for
determination of extrudability in terms of weight in grams
required to extrude a 0.5cm ribbon of gel in 10 seconds
from the collapsible tube.